Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Pathogen Recognition and Innate Immunity

Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,974 · see citing works

Inflammation, Atherosclerosis, and Coronary Artery Disease

Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773 · see citing works

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724 · see citing works

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117 · cited 1× · see citing works

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works

The Pathogenesis of Atherosclerosis — An Update

Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,885 · see citing works

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · see citing works

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 2× · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962 · see citing works

Immunological and inflammatory functions of the interleukin-1 family

Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · see citing works

Sterile inflammation: sensing and reacting to damage

Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · see citing works

Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression

Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,006 · see citing works

J. Submicrosc. Cytol. Pathol.

Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800 · see citing works

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655 · see citing works

C-Reactive Protein Levels and Outcomes after Statin Therapy

Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292 · see citing works

Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease

Danesh, J., Collins, R., Appleby, P. N., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,027 · see citing works

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024 · see citing works

Long-term use of ticagrelor in patients with prior myocardial infarction

Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., Magnani, G., Bansilal, S., Fish, M. P., Im, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500857 · Cited by 1,999 · see citing works

The interleukin-1 family: back to the future

Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945 · see citing works

Overview of the <scp>IL</scp> ‐1 family in innate inflammation and acquired immunity

Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866 · see citing works

Effect of Statin Therapy on C-Reactive Protein Levels

Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,642 · see citing works

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction&lt;SUBTITLE&gt;The IDEAL Study: A Randomized Controlled Trial&lt;/SUBTITLE&gt;

Pedersen, T. R. (2005) · JAMA · doi:10.1001/jama.294.19.2437 · Cited by 1,548 · see citing works

Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling

Chatzizisis, Y. S., Coskun, A. U., Jonas, M., Edelman, E. R., Feldman, C. L., & Stone, P. H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.059 · Cited by 1,483 · see citing works

Immune and Inflammatory Mechanisms of Atherosclerosis

Galkina, E., & Ley, K. F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,446 · see citing works

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

Jones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,392 · see citing works

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325 · see citing works

NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux

He, Y., Zeng, M. Y., Yang, D., Motro, B., & Núñez, G. (2016) · Nature · doi:10.1038/nature16959 · Cited by 1,295 · see citing works

Toll-Like Receptor Signaling Pathways

Barton, G. M., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1085536 · Cited by 1,270 · see citing works

Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.

Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,210 · see citing works

Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages*

Kunjathoor, V., Febbraio, M., Podrez, E., Moore, K., Andersson, L., Koehn, S. L., Rhee, J. S., Silverstein, R., Hoff, H., & Freeman, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209649200 · Cited by 1,064 · see citing works

Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease

Masters, S. L., Simon, A., Aksentijevich, I. A., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,063 · see citing works

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039 · see citing works

Toll-like Receptor 4 Polymorphisms and Atherogenesis

Kiechl, S. J., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024 · see citing works

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019 · see citing works

Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

Vasa‐Nicotera, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A. M., & Dimmeler, S. (2001) · Circulation · doi:10.1161/hc2401.092816 · Cited by 1,007 · see citing works

From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection

Ridker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002 · see citing works

Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques

Crisby, M., Fredrikson, G. N., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. Å. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 999 · see citing works

Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?

Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 936 · see citing works

Monocytes in atherosclerosis: subsets and functions

Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890 · see citing works

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876 · see citing works

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799 · see citing works

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 799 · see citing works

Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)

(1998) · Circulation · doi:10.1161/01.cir.97.15.1440 · Cited by 791 · see citing works

LOX-1, OxLDL, and Atherosclerosis

Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 768 · see citing works

Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748 · see citing works

Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB

Peng, H., Libby, P., & Liao, J. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.14214 · Cited by 703 · see citing works

Statins do more than just lower cholesterol

Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 699 · see citing works

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

Greenwood, J., Steinman, L., & Zamvil, S. S. (2006) · Nature reviews. Immunology · doi:10.1038/nri1839 · Cited by 685 · see citing works

Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL

Xu, X.-O. H., Shah, P. K., Faure, E., Equils, O., Thomas, L. S., Fishbein, M. C., Luthringer, D., Xu, X., Rajavashisth, T. B., Yano, J., et al. (2001) · Circulation · doi:10.1161/hc5001.100631 · Cited by 668 · see citing works

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

Frantz, S., Kobzik, L., Kim, Y., Fukazawa, R., Medzhitov, R. M., Lee, R. T., & Kelly, R. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6709 · Cited by 645 · see citing works

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Björkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634 · see citing works

In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

Morishita, R., Sugimoto, T., Aoki, M., Kida, I., Tomita, N., Moriguchi, A., Maeda, K., Sawa, Y., Kaneda, Y., Higaki, J., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-894 · Cited by 584 · see citing works

The evolving role of statins in the management of atherosclerosis

Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573 · see citing works

Modulation of atherosclerosis in mice by Toll-like receptor 2

Mullick, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25482 · Cited by 549 · see citing works

Chronic Infections and the Risk of Carotid Atherosclerosis

Kiechl, S. J., Egger, G., Mayr, M., Wiedermann, C. J., Bonora, E., Oberhollenzer, F., Muggeo, M., Xu, Q., Wick, G., Poewe, W. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1064 · Cited by 508 · see citing works

Association of endotoxemia with carotid atherosclerosis and cardiovascular disease

Wiedermann, C. J., Kiechl, S., Dunzendorfer, S., Schratzberger, P., Egger, G., Oberhollenzer, F., & Willeit, J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00448-9 · Cited by 505 · see citing works

Inflammation, Immunity, and HMG-CoA Reductase Inhibitors

Schönbeck, U., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000129505.34151.23 · Cited by 499 · see citing works

Interleukin‐1β, Interleukin‐18, and the Interleukin‐1β Converting Enzymea

Dinarello, C. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08307.x · Cited by 497 · see citing works

Inhibition of Tumor Necrosis Factor-α Reduces Atherosclerosis in Apolipoprotein E Knockout Mice

Brånén, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J. Å., & Jovinge, S. V. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143933.20616.1b · Cited by 495 · see citing works

Blocking IL-1 in systemic inflammation

Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494 · see citing works

Role of Lipoprotein-Associated Phospholipase A 2 in Atherosclerosis

Zalewski, A. A., & Macphee, C. H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 473 · see citing works

NOD-Like Receptors in Infection, Immunity, and Diseases

Kim, Y. K., Shin, J., & Nahm, M. H. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.1.5 · Cited by 460 · see citing works

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.

Pitt, B., Mancini, G., Ellis, S. G., Rosman, H. S., Park, J.-S., & McGovern, M. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00301-0 · Cited by 445 · see citing works

A novel anti-inflammatory role for simvastatin in inflammatory arthritis.

Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434 · see citing works

Inhibition of proinflammatory cytokine production by pravastatin

Rosenson, R. S., Tangney, C., & Casey, L. C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05917-0 · Cited by 376 · see citing works

The Biochemical and Cellular Basis of Cell Proliferation Assays That Use Tetrazolium Salts

Berridge, M. V., Tan, A. S., McCoy, K. D., & Wang, R. (1996) · Cited by 375 · see citing works

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 374 · see citing works

Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3

Coeshott, C. M., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6261 · Cited by 365 · see citing works

HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

Dichtl, W., Dulak, J., Frick, M., Alber, H., Schwarzacher, S., Ares, M., Nilsson, J., Pachinger, O., & Weidinger, F. (2003) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000043456.48735.20 · Cited by 345 · see citing works

Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

Ortego, M., Bustos, C., Hernández-Presa, M. Á., Tuñón, J., Díaz, C., Hernández, G., & Egido, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00193-8 · Cited by 342 · see citing works

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

Kostner, G. M., Gavish, D., Leopold, B., Bolzano, K., Weintraub, M. S., & Breslow, J. L. (1989) · Circulation · doi:10.1161/01.cir.80.5.1313 · Cited by 339 · see citing works

Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase.

Mizutani, H., Schechter, N. M., Lazarus, G. S., Black, R. A., & Kupper, T. S. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.821 · Cited by 317 · see citing works

Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease

Galea, J., Armstrong, J., Gadsdon, P., Holden, H. M., Francis, S., & Holt, C. M. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.8.1000 · Cited by 310 · see citing works

Anti-inflammatory therapeutics for the treatment of atherosclerosis

Charo, I. F., & Taub, R. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3444 · Cited by 309 · see citing works

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis

Paramel, G. V., Folkersen, L., Strawbridge, R. J., Halvorsen, B. L., Yndestad, A., Ranheim, T., Krohg‐Sørensen, K., Skjelland, M., Espevik, T., Aukrust, P., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003031 · Cited by 308 · see citing works

Inflammatory arthritis in caspase 1 gene–deficient mice: Contribution of proteinase 3 to caspase 1–independent production of bioactive interleukin‐1β

Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T. N., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25006 · Cited by 296 · see citing works

Statin treatment after onset of sepsis in a murine model improves survival.

Merx, M. W., Liehn, E. A., Graf, J., van de Sandt, A., Schaltenbrand, M., Schrader, J., Hanrath, P., & Weber, C. (2005) · Circulation · doi:10.1161/circulationaha.104.502195 · Cited by 287 · see citing works

Role of NLRP3 Inflammasomes in Atherosclerosis

Karasawa, T., & Takahashi, M. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17001 · Cited by 277 · see citing works

Role of TLR-2 in the Activation of Nuclear Factor κB by Oxidative Stress in Cardiac Myocytes

Frantz, S., Kelly, R. A., & Bourcier, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009160200 · Cited by 266 · see citing works

Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy

Rajesh, M., Bátkai, S., Kechrid, M., Mukhopadhyay, P., Lee, W.-S., Horváth, B., Holovac, E., Çınar, R., Liaudet, L., Mackie, K., et al. (2012) · Diabetes · doi:10.2337/db11-0477 · Cited by 255 · see citing works

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome

Menu, P., Pellegrin, M., Aubert, J.-F., Bouzourène, K., Tardivel, A., Mazzolai, L., & Tschopp, J. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.18 · Cited by 249 · see citing works

In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions

Vink, A., Schoneveld, A. H., van der Meer, J. J., van Middelaar, B. J., Sluijter, J. P. G., Smeets, M. B., Quax, P. H. A., Lim, S. K., Borst, C., Pasterkamp, G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000032146.75113.ee · Cited by 243 · see citing works

Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse

Toldo, S. A., Marchetti, C., Mauro, A. G., Chojnacki, J. E., Mezzaroma, E., Carbone, S., Zhang, S., Tassell, B. W. V., Salloum, F. N., & Abbate, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.043 · Cited by 242 · see citing works

Genetic Analysis of the Interleukin-18 System Highlights the Role of the Interleukin-18 Gene in Cardiovascular Disease

Tiret, L., Godefroy, T., Lubos, E., Nicaud, V., Trégouët, D., Barbaux, S., Schnabel, R. B., Bickel, C., Espinola–Klein, C., Poirier, O., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.519702 · Cited by 229 · see citing works

Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis

Dewberry, R. M., Holden, H. M., Crossman, D. C., & Francis, S. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2394 · Cited by 228 · see citing works

Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake

Choi, S.-H., Harkewicz, R., Lee, J. H., Boullier, A., Almazan, F., Li, A. C., Witztum, J. L., Bae, Y. S., & Miller, Y. I. (2009) · Circulation Research · doi:10.1161/circresaha.108.192880 · Cited by 227 · see citing works

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

Bhaskar, V., Yin, J., Mirza, A. M., Phan, D., Vanegas, S., Issafras, H., Michelson, K. S., Hunter, J., & Kantak, S. S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.026 · Cited by 226 · see citing works

Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents

Thurnher, M., Nussbaumer, O., & Gruenbacher, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0489 · Cited by 226 · see citing works

Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events

Boekholdt, S. M., Agema, W. R. P., Peters, R. J. G., Zwinderman, A. H., van der Wall, E. E., Reitsma, P. H., Kastelein, J. J. P., & Jukema, J. W. (2003) · Circulation · doi:10.1161/01.cir.0000068311.40161.28 · Cited by 224 · see citing works

The role of the NLRP3 inflammasome in gout

McDermott, M., Kingsbury, S. R., & Conaghan, P. G. (2011) · Journal of Inflammation Research · doi:10.2147/jir.s11330 · Cited by 221 · see citing works

The NLRP3 inflammasome: A sensor of immune danger signals

Cassel, S. L., Joly, S., & Sutterwala, F. S. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.002 · Cited by 217 · see citing works

Effect of Cholesterol Crystals on Plaques and Intima in Arteries of Patients With Acute Coronary and Cerebrovascular Syndromes

Abela, G. S., Aziz, K. S., Vedre, A., Pathak, D. R., Talbott, J. D., & deJong, J. L. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.12.019 · Cited by 215 · see citing works

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy

Luo, B., Huang, F., Liu, Y., Liang, Y., Wei, Z., Ke, H., Zeng, Z., Huang, W., & He, Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00519 · Cited by 213 · see citing works

TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis

Michelsen, K. S., Doherty, T. M., Shah, P. K., & Arditi, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.5901 · Cited by 211 · see citing works

Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction

Vilahur, G., Juan‐Babot, O., Peña, E., Oñate, B., Casaní, L., & Badimón, L. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.021 · Cited by 209 · see citing works

NLRP3 inflammasome pathways in atherosclerosis

Baldrighi, M., Mallat, Z., & Li, X. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.027 · Cited by 202 · see citing works

Inflammation and Atherothrombosis

Libby, P., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.011 · Cited by 200 · see citing works

Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-κB- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by Atorvastatin

Chandrasekar, B., Mummidi, S., Mahimainathan, L., Patel, D. N., Bailey, S. R., Imam, S. Z., Greene, W. C., & Valente, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600200200 · Cited by 194 · see citing works

Innate immune signals in atherosclerosis

Lundberg, A. M., & Hansson, G. K. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.016 · Cited by 194 · see citing works

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms

Chruściel, P., Sahebkar, A., Rembek, M., Șerban, M.-C., Ursoniu, S., Mikhailidis, D. P., Jones, S. R., Moșteoru, S., Blaha, M. J., Martin, S. S., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.897 · Cited by 194 · see citing works

Inflammation and Atherosclerosis

Jialal, I., & Devaraj, S. (2001) · Pathology Patterns Reviews · doi:10.1309/j63v-5lth-wyfc-vdr5 · Cited by 192 · see citing works

Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation

Abela, G. S. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.03.003 · Cited by 189 · see citing works

Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation?

Andreakos, E., Foxwell, B. M. J., & Feldmann, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00202.x · Cited by 188 · see citing works

Innate immunity and toll-like receptors: clinical implications of basic science research

Abreu, M. T., & Arditi, M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.057 · Cited by 182 · see citing works

Simvastatin Therapy Reduces Prooxidant‐Antioxidant Balance: Results of a Placebo‐Controlled Cross‐Over Trial

Parizadeh, S. M. R., Azarpazhooh, M. R., Moohebati, M., Nematy, M., Ghayour‐Mobarhan, M., Tavallaie, S., Rahsepar, A. A., Amini, M., Sahebkar, A., Mohammadi, M., et al. (2011) · Lipids · doi:10.1007/s11745-010-3517-x · Cited by 182 · see citing works

The impact of statin therapy on plasma levels of von Willebrand factor antigen

Sahebkar, A., Șerban, M.-C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Bittner, V., Ray, K. K., Watts, G. F., Hovingh, G. K., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-08-0620 · Cited by 180 · see citing works

Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials

Sahebkar, A., Kotani, K., Șerban, M.-C., Ursoniu, S., Mikhailidis, D. P., Jones, S. R., Ray, K. K., Blaha, M. J., Rysz, J., Toth, P. P., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.022 · Cited by 178 · see citing works

New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?

Sahebkar, A., & Watts, G. F. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6479-4 · Cited by 176 · see citing works

Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis

Shi, X., Xie, W., Kong, W.-W., Chen, D., & Qu, P. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.03.024 · Cited by 173 · see citing works

Expression ofmiR-146a/bis associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin–angiotensin system blockade and statins onmiRNA-146a/band Toll-like receptor 4 levels

Takahashi, Y., Satoh, M., Minami, Y., Tabuchi, T., Itoh, T., & Nakamura, M. (2010) · Clinical Science · doi:10.1042/cs20100003 · Cited by 173 · see citing works

Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14 ⁺ Monocytes

Methe, H., Kim, J.-O., Kofler, S., Nabauer, M., & Weis, M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168410.44722.86 · Cited by 172 · see citing works

Toll like receptor 4 in atherosclerosis and plaque destabilization

den Dekker, W. K., Cheng, C., Pasterkamp, G., & Duckers, H. J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.075 · Cited by 171 · see citing works

CX 3 CR1 Deficiency Impairs Dendritic Cell Accumulation in Arterial Intima and Reduces Atherosclerotic Burden

Liu, P., Yu, Y.-R. A., Spencer, J. A., Johnson, A. E., Vallanat, C. T., Fong, A. M., Patterson, C., & Patel, D. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158675 · Cited by 168 · see citing works

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus

van de Ree, M. A., Huisman, M. V., Princen, H. M. G., Meinders, A. E., & Kluft, C. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00316-7 · Cited by 159 · see citing works

Association between statin use and plasma D-dimer levels

Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Muntner, P., Bittner, V., Ray, K. K., Watts, G. F., Hovingh, G. K., Rysz, J., Kastelein, J. J. P., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-11-0937 · Cited by 156 · see citing works

Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo

Niessner, A., Steiner, S., Speidl, W. S., Pleiner, J., Seidinger, D., Maurer, G., Goronzy, J. J., Weyand, C. M., Kopp, C. W., Huber, K., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.022 · Cited by 154 · see citing works

Modulation of inflammatory mediators and pparγand nfκb expression by pravastatin in response to lipoproteins in human monocytes in vitro

Zelvyté, I., Dominaitiene, R., Crisby, M., & Janciauskiene, S. M. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0922 · Cited by 152 · see citing works

Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model

Luo, B., Li, B., Wang, W., Liu, X., Liu, X., Xia, Y., Zhang, C., Zhang, Y., Zhang, M., & An, F. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6498-1 · Cited by 150 · see citing works

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice

Zheng, F. Y., Xing, S., Gong, Z., Mu, W., & Xing, Q. (2014) · Mediators of Inflammation · doi:10.1155/2014/507208 · Cited by 147 · see citing works

Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size

Devlin, C. M., Kuriakose, G., Hirsch, E., & Tabas, I. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092324399 · Cited by 147 · see citing works

LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis

Ding, Z., Liu, S., Wang, X., Dai, Y., Khaidakov, M., Deng, X., Fan, Y., Xiang, D., & Mehta, J. L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu114 · Cited by 145 · see citing works

Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in mice

Gojová, A., Brun, V., Esposito, B., Cottrez, F., Gourdy, P., Ardouin, P., Tedgui, A., Mallat, Z., & Groux, H. (2003) · Blood · doi:10.1182/blood-2003-05-1729 · Cited by 145 · see citing works

Simvastatin Modulates Cytokine-Mediated Endothelial Cell Adhesion Molecule Induction: Involvement of an Inhibitory G Protein

Sadeghi, M. M., Collinge, M., Pardi, R., & Bender, J. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2712 · Cited by 144 · see citing works

TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model

Ti, Y., Xie, G.-L., Wang, Z., Bi, X., Ding, W., Wang, J., Jiang, G.-H., Bu, P. L., Zhang, Y., Zhong, M., et al. (2011) · Diabetes · doi:10.2337/db11-0549 · Cited by 143 · see citing works

Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance

Henriksbo, B. D., Lau, T. C., Cavallari, J. F., Denou, E., Chi, W., Lally, J., Crane, J. D., Duggan, B. M., Foley, K. P., Fullerton, M. D., et al. (2014) · Diabetes · doi:10.2337/db13-1398 · Cited by 141 · see citing works

Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome Activation

Xu, J., Washko, G. R., Nakahira, K., Hatabu, H., Patel, A. S., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1574oc · Cited by 140 · see citing works

Platelet P2Y 12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Thomas, M. R., Outteridge, S. N., Ajjan, R., Phoenix, F. A., Sangha, G. K., Faulkner, R. E., Ecob, R., Judge, H. M., Khan, H. Z., West, L. E., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306528 · Cited by 136 · see citing works

Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size

Nanhwan, M. K., Ling, S., Kodakandla, M., Nylander, S., Ye, Y., & Birnbaum, Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304002 · Cited by 134 · see citing works

P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation

Kuang, P., Liu, L.-S., Wei, D., Lv, Y.-C., Wang, G., Xiong, W., Wang, X., Altaf, A., Wang, L., He, D., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2129 · Cited by 131 · see citing works

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin

Satoh, M., Tabuchi, T., Itoh, T., & Nakamura, M. (2013) · Clinical Science · doi:10.1042/cs20130043 · Cited by 126 · see citing works

Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways

Özbek, E., Çekmen, M., İlbey, Y. Ö., Şimşek, A., Polat, E. C., & Somay, A. (2009) · Renal Failure · doi:10.1080/08860220902835863 · Cited by 124 · see citing works

Protective Effects of Ticagrelor on Myocardial Injury After Infarction

Vilahur, G., Gutiérrez, M., Casaní, L., Varela, L. M., Capdevila, A., Pons‐Lladó, G., Carreras, F., Carlsson, L. G., Hidalgo, A., & Badimón, L. (2016) · Circulation · doi:10.1161/circulationaha.116.024014 · Cited by 124 · see citing works

Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes

Kong, F., Ye, B., Lü, L., Cai, X., Huang, W., & Huang, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.043 · Cited by 123 · see citing works

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells

Hernández-Presa, M. Á., Martı́n-Ventura, J. L., Ortego, M., Gómez‐Hernández, A., Tuñón, J., Hernández-Vargas, P., Blanco‐Colio, L. M., Mas, S., Aparicio, C., Ortega, L. M., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00547-0 · Cited by 122 · see citing works

Inhibition of nuclear factor-erythroid 2–related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence

Volonte, D., Liu, Z., Musille, P. M., Stoppani, E., Wakabayashi, N., Di, Y.-P., Lisanti, M. P., Kensler, T. W., & Galbiati, F. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-09-0666 · Cited by 119 · see citing works

Therapeutic potential of statins in Alzheimer's disease

Kandiah, N., & Feldman, H. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.352 · Cited by 114 · see citing works

The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases

Lin, Q., Li, M., Fang, D., Fang, J., & Su, S. B. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.026 · Cited by 105 · see citing works

P2X 7 Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice

Stachon, P., Heidenreich, A., Merz, J., Hilgendorf, I., Wolf, D., Willecke, F., von Garlen, S., Albrecht, P., Härdtner, C., Ehrat, N., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027400 · Cited by 105 · see citing works

New Insights into Plaque Stabilisation by Lipid Lowering

Libby, P., & Aikawa, M. (1998) · Drugs · doi:10.2165/00003495-199856001-00002 · Cited by 104 · see citing works

Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.

Birks, E., Felkin, L., Banner, N., Khaghani, A., Barton, P., & Yacoub, M. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(03)00106-2 · Cited by 102 · see citing works

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis

Yang, I. A. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00286-7 · Cited by 101 · see citing works

Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells.

Montero, M. T., Hernández, O., Suárez, Y., Matilla, J., Ferruelo, A. J., Martı́nez-Botas, J., Gómez-Coronado, D., & Lasunción, M. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00417-2 · Cited by 97 · see citing works

Oxidized Low‐Density Lipoprotein (OxLDL)–Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let‐7c Is Integral to the Effect

Frostegård, J., Zhang, Y., Sun, J., Yan, K., & Liu, A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003976 · Cited by 95 · see citing works

Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNFα in Vascular Endothelial Cells through a PXR-Dependent Mechanism

Wang, S., Xie, X., Lei, T., Zhang, K., Lai, B., Zhang, Z., Guan, Y., Mao, G., Xiao, L., & Wang, N. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.108100 · Cited by 93 · see citing works

Lipids, blood pressure and kidney update 2014

Banach, M., Aronow, W. S., Șerban, M.-C., Sahabkar, A., Rysz, J., Voroneanu, L. E., & Covic, A. C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.009 · Cited by 92 · see citing works

Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes

Yamamoto, A., Hoshi, K., & Ichihara, K. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00692-x · Cited by 90 · see citing works

Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism

Mason, R. P., Walter, M. F., Day, C. A., & Jacob, R. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513000200 · Cited by 86 · see citing works

Atorvastatin suppresses interferon-γ-induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines

Neurauter, G., Wirleitner, B., Laich, A., Schennach, H., WEISS, G., & Fuchs, D. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02021.x · Cited by 85 · see citing works

Statin synergizes with LPS to induce IL-1β release by THP-1 cells through activation of caspase-1

Kuijk, L. M., Mandey, S. H. L., Schellens, I. M. M., Waterham, H. R., Rijkers, G. T., Coffer, P. J., & Frenkel, J. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.12.008 · Cited by 84 · see citing works

Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction

Holloway, J. W., Yang, I. A., & Ye, S. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200501000-00003 · Cited by 83 · see citing works

Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?

Arboix, A., García‐Eroles, L., Oliveres, M., Targa, C., Balcells, M., & Massons, J. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-47 · Cited by 83 · see citing works

Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury

Shishido, T., Nozaki, N., Takahashi, H., Arimoto, T., Niizeki, T., Koyama, Y., Abe, J., Takeishi, Y., & Kubota, I. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.056 · Cited by 83 · see citing works

TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study

on behalf of the PRIME Study group, Morange, P., Tiret, L., Saut, N., Luc, G., Arveiler, D., Ferrières, J., Amouyel, P., Evans, A., Ducimetière, P., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201277 · Cited by 82 · see citing works

The role of the inflammasome in patients with autoinflammatory diseases

Hoffman, H. M., & Broderick, L. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.001 · Cited by 79 · see citing works

Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway

Yuan, X., Deng, Y., Guo, X., Shang, J., Zhu, D., & Liu, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.091 · Cited by 78 · see citing works

Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF

Zaitone, S. A., & Abogresha, N. M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.06.022 · Cited by 78 · see citing works

NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins

Altaf, A., Qu, P., Zhao, Y., Wang, H., Lou, D., & Niu, N. (2015) · Coronary Artery Disease · doi:10.1097/mca.0000000000000255 · Cited by 77 · see citing works

Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: Effect of statins on let-7i and Toll-like receptor 4 signal

Satoh, M., Tabuchi, T., Minami, Y., Takahashi, Y., Itoh, T., & Nakamura, M. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.08.005 · Cited by 71 · see citing works

Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr−/− mice

Hendrikx, T., Jeurissen, M. L. J., van Gorp, P. J., Gijbels, M. J., Walenbergh, S. M. A., Houben, T., van Gorp, R. H., Pöttgens, C. C. H., Stienstra, R., Netea, M. G., et al. (2015) · FEBS Journal · doi:10.1111/febs.13279 · Cited by 71 · see citing works

IL-1 Cytokines in Cardiovascular Disease: Diagnostic, Prognostic and Therapeutic Implications

Apostolakis, S. Z., Vogiatzi, K., Krambovitis, E., & Spandidos, D. A. (2008) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152508783955006 · Cited by 71 · see citing works

Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure

Földes, G., von Haehling, S., Okonko, D. O., Jankowska, E. A., Poole-Wilson, P. A., & Anker, S. D. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.12.024 · Cited by 66 · see citing works

Lovastatin inhibits lipopolysaccharide-induced NF-kB activation in human mesangial cells

Guijarro, C., Kim, Y., Schoonover, C. M., Massy, Z. A., O’Donnell, M. P., Kasiske, B. L., Keane, W. F., & Kashtan, C. E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.6.990 · Cited by 65 · see citing works

Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?

Ridker, P. M. (2013) · Europe PMC (PubMed Central) · Cited by 64 · see citing works

The Alternative Pathway Is Critical for Pathogenic Complement Activation in Endotoxin- and Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Malik, T. H., Cortini, A., Carassiti, D., Boyle, J. J., Haskard, D. O., & Botto, M. (2010) · Circulation · doi:10.1161/circulationaha.110.981365 · Cited by 64 · see citing works

Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide – Induced cytokine production in monocytes of hypercholesterolemic patients

Moutzouri, E., Tellis, C. C., Rousouli, K., Liberopoulos, E. N., Milionis, H. J., Elisaf, M., & Tselepis, A. D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.037 · Cited by 61 · see citing works

Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve

Versteeg, D., Hoefer, I. E., Schoneveld, A. H., de Kleijn, D. P. V., Busser, E., Strijder, C. F., Emons, M., Stella, P. R., Doevendans, P. A., & Pasterkamp, G. (2007) · Heart · doi:10.1136/hrt.2007.117259 · Cited by 59 · see citing works

Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells

Wang, Y., Zhang, M. X., Meng, X., Liu, F. Q., Yu, G. S., Zhang, C., Sun, T., Wang, X. P., Li, L., Wang, Y. Y., et al. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01335.2008 · Cited by 59 · see citing works

Induction of Dendritic Cell–Mediated T-Cell Activation by Modified but Not Native Low-Density Lipoprotein in Humans and Inhibition by Annexin A5

Liu, A., Ming, J. Y., Fiskesund, R., Ninio, E., Karabina, S., Bergmark, C., Frostegård, A. G., & Frostegård, J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304342 · Cited by 57 · see citing works

HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation

Liao, Y.-H., Lin, Y.-C., Tsao, S.-T., Lin, Y., Yang, A.-J., Huang, C.-T., Huang, K., & Lin, W. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812409 · Cited by 56 · see citing works

Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine

Birnbaum, Y., Birnbaum, G. D., Birnbaum, I., Nylander, S., & Ye, Y. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6701-2 · Cited by 54 · see citing works

Toll Receptor Polymorphisms and Carotid Artery Intima-Media Thickness

Labrum, R. W., Bevan, S., Sitzer, M., Lorenz, M., & Markus, H. S. (2007) · Stroke · doi:10.1161/01.str.0000260184.85257.2b · Cited by 54 · see citing works

Toll-like Receptor Polymorphisms and Carotid Artery Intima-Media Thickness

Lepper, P. M., von Eynatten, M., Humpert, P. M., Triantafilou, M., & Triantafilou, K. (2007) · Stroke · doi:10.1161/strokeaha.107.487058 · Cited by 53 · see citing works

Statins as potential therapeutic drug for asthma?

Yuan, C., Zhou, L., Cheng, J., Zhang, J., Teng, Y., Huang, M., Adcock, I. M., Barnes, P. J., & Yao, X. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-108 · Cited by 52 · see citing works

Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway.

Chansrichavala, P., Chantharaksri, U., Sritara, P., & Chaiyaroj, S. C. (2009) · PubMed · Cited by 51 · see citing works

LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors

de Bont, N., Netea, M. G., Bleeker‐Rovers, C. P., Smilde, T. J., Demacker, P. N. M., van der Meer, J. W. M., & Stalenhoef, A. F. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00074-4 · Cited by 50 · see citing works

Characterization of the Expression of TLR2 (Toll-like Receptor 2) and TLR4 on Circulating Monocytes in Coronary Artery Disease

Ashida, K., Miyazaki, K., Takayama, E., Tsujimoto, H., Ayaori, M., Yakushiji, T., Iwamoto, N., Yonemura, A., Isoda, K., Mochizuki, H., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.53 · Cited by 48 · see citing works

TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis

Doherty, T. M., Fisher, E. A. A., & Arditi, M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.03.006 · Cited by 46 · see citing works

Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress

Tian, X., Wong, W. T., Xu, A., Chen, Z., Lu, Y., Lm, L., Lee, V. W. Y., Lau, C., Yao, X., & Huang, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01416.x · Cited by 46 · see citing works

Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke

Protopsaltis, J., Kokkoris, S., Korantzopoulos, P. G., Milionis, H. J., Karzi, E., Anastasopoulou, A., Filioti, K., Antonopoulos, S., Melidonis, A. J., & Giannoulis, G. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.042 · Cited by 44 · see citing works

Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment

Kapelouzou, A., Giaglis, S., Peroulis, M., Katsimpoulas, M., Moustardas, P., Aravanis, C. V., Kostakis, A. I., Karayannakos, P. E., & Cokkinos, D. V. (2017) · Journal of Vascular Research · doi:10.1159/000457797 · Cited by 44 · see citing works

Is immunity a mechanism contributing to statin-induced diabetes?

Henriksbo, B. D., & Schertzer, J. D. (2015) · Adipocyte · doi:10.1080/21623945.2015.1024394 · Cited by 43 · see citing works

Geranylgeraniol Regulates Negatively Caspase-1 Autoprocessing: Implication in the Th1 Response against Mycobacterium tuberculosis

Montero, M. T., Matilla, J., Gómez-Mampaso, E., & Lasunción, M. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4936 · Cited by 43 · see citing works

Atorvastatin affects TLR4 clustering via lipid raft modulation

Chansrichavala, P., Chantharaksri, U., Sritara, P., Kosoltanapiwat, N., & Chaiyaroj, S. C. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.04.027 · Cited by 40 · see citing works

Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin–angiotensin system blockade

Satoh, M., Takahashi, Y., Tabuchi, T., Tamada, M., Takahashi, K., Itoh, T., Morino, Y., & Nakamura, M. (2014) · Clinical Science · doi:10.1042/cs20140417 · Cited by 38 · see citing works

Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression

Hodgkinson, C. P., & Ye, S. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283050aff · Cited by 36 · see citing works

Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes

Lv, Z.-H., Phuong, T. A., Jin, S., Li, X.-X., & Xu, M. (2017) · Oncotarget · doi:10.18632/oncotarget.20443 · Cited by 36 · see citing works

Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes

Massonnet, B., Normand, S., Moschitz, R., Delwail, A., Favot, L., Garcia, M., Bourmeyster, N., Cuisset, L., Grateau, G., Morel, F., et al. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0162 · Cited by 35 · see citing works

Statin-Induced Insulin Resistance Through Inflammasome Activation: Sailing Between Scylla and Charybdis

Mitchell, P. L., & Marette, A. (2014) · Diabetes · doi:10.2337/db14-1059 · Cited by 34 · see citing works

The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end‐stage hypertension in rats

Zhang, W. B., Du, Q., Li, H., Sun, A., Qiu, Z., Wu, C. N., Zhao, G., Gong, H., Hu, K., Zou, Y., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01536.x · Cited by 33 · see citing works

Rosuvastatin Attenuates Monocyte-Endothelial Cell Interactions and Vascular Free Radical Production in Hypercholesterolemic Mice

Li, W., Asagami, T., Matsushita, H., Lee, K.-H., & Tsao, P. S. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080002 · Cited by 31 · see citing works

3-Hydroxyl-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor (Statin)-induced 28-kDa Interleukin-1β Interferes with Mature IL-1β Signaling

Davaro, F., Forde, S., Garfield, M. K., Jiang, Z., Halmen, K. A., Tamburro, N. D., Kurt‐Jones, E. A., Fitzgerald, K. A., Golenbock, D. T., & Wang, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571505 · Cited by 31 · see citing works

Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells

Yang, S. S., Li, R.-G., Qu, X., Fang, W., & Quan, Z. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.09.008 · Cited by 30 · see citing works

The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients

Koksal, M., Eren, M. A., Turan, M. N., & Sabuncu, T. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.12.003 · Cited by 29 · see citing works

Effect of atorvastatin on expression of TLR4 and NF-κB p65 in atherosclerotic rabbits

Shen, D., Xin, S.-L., Chen, C., & Liu, T. (2013) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(13)60081-4 · Cited by 28 · see citing works

Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity

Hernesniemi, J. A., Raitakari, O. T., Kähönen, M. A. P., Juonala, M., Hutri‐Kähönen, N., Marniemi, J., Viikari, J. S. A., & Lehtimäki, T. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.024 · Cited by 27 · see citing works

Effects of HMG-CoA Reductase Inhibitor on Experimental Autoimmune Myocarditis

Liu, X., Li, B., Wang, W., Zhang, C., Zhang, M., Zhang, Y., Xia, Y., Dong, Z., Guo, Y. L., & An, F. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6372-6 · Cited by 27 · see citing works

The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4

Yang, J., Zhang, X.-D., Yang, J. M., Ding, J., Liu, Z., Li, S.-G., & Yang, R. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-9970-z · Cited by 27 · see citing works

Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals

Boland, A. J., Gangadharan, N., Kavanagh, P. V., Hemeryck, L., Kieran, J., Barry, M. G., Walsh, P. T., & Lucitt, M. B. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418776261 · Cited by 26 · see citing works

Ultrastructural evidence for association of vascular dendritic cells with T-lymphocytes and with B-cells in human atherosclerosis.

Bobryshev, Y. V., & Watanabe, T. (1997) · PubMed · Cited by 25 · see citing works

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183 · see citing works

Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases

Bai, J., Zhang, Y., Tang, C., Hou, Y., Ai, X., Chen, X., Zhang, Y., Wang, X., & Meng, X. (2021) · Biomedicine &amp; Pharmacotherapy · doi:10.1016/j.biopha.2020.110985 · Cited by 720 · see citing works

The Role of Inflammation in Diabetic Retinopathy

Forrester, J. V., Kuffová, L., & Delibegović, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583687 · Cited by 448 · see citing works

Arterial stiffness and vascular aging: mechanisms, prevention, and therapy

Herzog, M. J., Müller, P., Lechner, K., Stiebler, M., Arndt, P., Kunz, M., Ahrens, D., Schmeißer, A., Schreiber, S., & Braun-Dullaeus, R. C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02346-0 · Cited by 246 · see citing works

Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity.

Henning, R. J. (2021) · Europe PMC (PubMed Central) · Cited by 169 · see citing works

A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies

Netala, V. R., Teertam, S. K., Li, H., & Zhang, Z. (2024) · Cells · doi:10.3390/cells13171471 · Cited by 181 · see citing works

Cholesterol in Relation to COVID-19: Should We Care about It?

Radenković, D., Chawla, S., Pirro, M., Sahebkar, A., & Banach, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061909 · Cited by 148 · see citing works

“Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression

Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 152 · see citing works

Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics

Pickett, J. R., Wu, Y., Zacchi, L. F., & Ta, H. T. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad130 · Cited by 138 · see citing works

Challenges and advances in the management of inflammation in atherosclerosis

Xing, Y., & Lin, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.016 · Cited by 142 · see citing works

2021 update on thyroid-associated ophthalmopathy

Neag, E. J., & Smith, T. J. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01663-9 · Cited by 104 · see citing works

Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics

Jin, M., Fang, J. C., Wang, J., Shao, X., Xu, S., Liu, P., Ye, W., & Liu, Z. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01123-5 · Cited by 102 · see citing works

Immunometabolism and immune response regulate macrophage function in atherosclerosis

Xue, S., Su, Z., & Liu, D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101993 · Cited by 94 · see citing works

Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery

He, J., Zhang, W., Zhou, X., Xu, F., Zou, J., Zhang, Q., Zhao, Y., He, H., Yang, H., & Liu, J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.041 · Cited by 87 · see citing works

Gold Nanoparticles: Multifaceted Roles in the Management of Autoimmune Disorders

Koushki, K., Shahbaz, S. K., Keshavarz, M., Bezsonov, E. E., Sathyapalan, T., & Sahebkar, A. (2021) · Biomolecules · doi:10.3390/biom11091289 · Cited by 82 · see citing works

A comprehensive review of the advances in neuromyelitis optica spectrum disorder.

Siriratnam, P., Huda, S., Butzkueven, H., van der Walt, A., Jokubaitis, V., & Monif, M. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103465 · Cited by 75 · see citing works

Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle

Dehghani, T., & Panitch, A. (2020) · Open Biology · doi:10.1098/rsob.200161 · Cited by 73 · see citing works

Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review

Živković, S., Maric, G. D., Cvetinovic, N., Lepojevic-Stefanovic, D., & Božić, B. (2023) · Nutrients · doi:10.3390/nu15061517 · Cited by 74 · see citing works

Quercetin reduces inflammation in a rat model of diabetic peripheral neuropathy by regulating the TLR4/MyD88/NF-κB signalling pathway

Zhao, B., Zhang, Q., Liang, X., Xie, J. X., & Sun, Q. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174607 · Cited by 71 · see citing works

Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities

Stroope, C., Nettersheim, F. S., Coon, B. G., Finney, A. C., Schwartz, M. A., Ley, K. F., Rom, O., & Yurdagul, A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01015-w · Cited by 72 · see citing works

Molecular targets of statins and their potential side effects: Not all the glitter is gold

Patel, K. K., Sehgal, V. S., & Kashfi, K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174906 · Cited by 73 · see citing works

Toll‐like receptors in health and disease

Wang, K., Huang, H., Qi, Z., Ding, H., & Li, Y. (2024) · MedComm · doi:10.1002/mco2.549 · Cited by 68 · see citing works

Chronic oral exposure to cadmium causes liver inflammation by NLRP3 inflammasome activation in pubertal mice

Li, X., Li, H., Cai, D., Li, P., Jin, J., Jiang, X., Li, Z., Tian, L., Chen, G., Sun, J., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111944 · Cited by 66 · see citing works

The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism

Warren, T., McAllister, R., Morgan, A. E., Singh, T., McGilligan, V., Ennis, M., Page, C. J., Kelly, C., Peace, A. J., Corfe, B. M., et al. (2021) · Cells · doi:10.3390/cells10082007 · Cited by 65 · see citing works

In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis

Permana, H., Huang, I., Purwiga, A., Kusumawardhani, N. Y., Sihite, T. A., Martanto, E., Wisaksana, R., & Soetedjo, N. N. M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00233-3 · Cited by 64 · see citing works

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Ruscica, M., Penson, P. E., Ferri, N., Sirtori, C. R., Pirro, M., Mancini, G. B. J., Sattar, N. A., Toth, P. P., Sahebkar, A., Lavie, C. J., et al. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.06.010 · Cited by 64 · see citing works

The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations

Theofilis, P., Oikonomou, E. K., Tsioufis, K. P., & Tousoulis, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119568 · Cited by 62 · see citing works

The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders

Kosowski, M., Smolarczyk, J., Hachuła, M., Maligłówka, M., Basiak, M., Machnik, G., Pudło, R., & Okopień, B. (2021) · Molecules · doi:10.3390/molecules26102838 · Cited by 58 · see citing works

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms

Hedayati, N., Yaghoobi, A., Salami, M., Gholinezhad, Y., Aghadavood, F., Eshraghi, R., Aarabi, M. H., Homayoonfal, M., Asemi, Z., Mirzaei, H., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1174816 · Cited by 57 · see citing works

Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity

Behzadifard, M., Fard, S. B., Ramazi, S., Atashi, A., & Eslamifar, Z. (2021) · Thrombosis Journal · doi:10.1186/s12959-021-00311-9 · Cited by 53 · see citing works

Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table

Cosentino, F., Verma, S., Ambery, P., Treppendahl, M. B., van Eickels, M., Anker, S. D., Cecchini, M., Fioretto, P., Groop, P., Hess, D. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad445 · Cited by 56 · see citing works

Astilbin protects from sepsis‐induced cardiac injury through the NRF2 / HO ‐1 and TLR4 / NF‐κB pathway

Fang, Z., Wang, G., Huang, R., Liu, C., Yushanjiang, F., Mao, T., & Li, J. (2023) · Phytotherapy Research · doi:10.1002/ptr.8093 · Cited by 48 · see citing works

Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated with Atorvastatin Intake by Targeting Cerebral miRNA155 and NLRP3: In Vivo, and In Silico Study

Mohamed, D. I., El-Waseef, D. A. E.-D. A., Nabih, E. S., El-Kharashi, O. A., El-Kareem, H. F. A., Nahas, H. H. A., Abdel‐Wahab, B. A., Helmy, Y. A., Alshawwa, S. Z., & Saied, E. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030529 · Cited by 44 · see citing works

A Novel Sustained Anti-Inflammatory Effect of Atorvastatin—Calcium PLGA Nanoparticles: In Vitro Optimization and In Vivo Evaluation

Abdelkader, D. H., Abosalha, A. K., Khattab, M. A., Aldosari, B. N., & Almurshedi, A. S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101658 · Cited by 43 · see citing works

Black chokeberry ( Aronia melanocarpa L.) polyphenols attenuate obesity-induced colonic inflammation by regulating gut microbiota and the TLR4/NF-κB signaling pathway in high fat diet-fed rats

Zhu, Y., Cai, P.-J., Dai, H.-C., Xiao, Y., Jia, C., & Sun, A. (2023) · Food & Function · doi:10.1039/d3fo02177g · Cited by 42 · see citing works

Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management

Cacciatore, S., Andaloro, S., Bernardi, M., Manzanas, A. O., Spadafora, L., Figliozzi, S., Asher, E., Rana, J. S., Ecarnot, F., Gragnano, F., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073071 · Cited by 45 · see citing works

Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis

Hafiane, A., & Daskalopoulou, S. S. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106157 · Cited by 40 · see citing works

Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study

Santosa, A., Franzén, S., Nåtman, J., Wettermark, B., Parmryd, I., & Nyberg, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-16357-2 · Cited by 39 · see citing works

Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations

Ahmadi, Y., Fard, J. K., Ghafoor, D. D., Eid, A. H., & Sahebkar, A. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02890-1 · Cited by 39 · see citing works

Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia

Chang, W., Lin, H., Lin, S., & Li, Y. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.9515 · Cited by 39 · see citing works

Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review

Messina, A., Concerto, C., Rodolico, A., Petralia, A., Caraci, F., & Signorelli, M. S. (2023) · Brain Sciences · doi:10.3390/brainsci13060957 · Cited by 39 · see citing works

Mechanosensitive Piezo1 Channel Evoked-Mechanical Signals in Atherosclerosis

Shinge, S. A. U., Zhang, D., Muluh, T. A., Nie, Y., & Yu, F. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s319789 · Cited by 38 · see citing works

Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches

Gauer, J. S., Ajjan, R., & Ariëns, R. A. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027071 · Cited by 40 · see citing works

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease

Baragetti, A., Catapano, A. L., & Magni, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124459 · Cited by 38 · see citing works

Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease

Perrelli, A., & Retta, S. F. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.021 · Cited by 38 · see citing works

Long-Term Outcome and Prognosis of Noninfectious Thoracic Aortitis

Espitia, O., Bruneval, P., Assaraf, M., Pouchot, J., Liozon, É., de Boysson, H., Gaudric, J., Chiche, L., Achouh, P., Roussel, J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.06.031 · Cited by 37 · see citing works

Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching

Lohia, P., Kapur, S., Benjaram, S., & Mir, T. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.03.002 · Cited by 37 · see citing works

Effect of Statins on Prevalence and Mortality of Influenza Virus Infection: A Systematic Review and Meta-Analysis

Vahedian‐Azimi, A., Mannarino, M. R., Shojaie, S., Rahimi‐Bashar, F., Galeh, H. E. G., Banach, M., Bianconi, V., Pirro, M., & Sahebkar, A. (2022) · Archives of Medical Science · doi:10.5114/aoms/149633 · Cited by 37 · see citing works

Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer

Batiha, G. E., Al-Gareeb, A. I., Rotimi, D., Adeyemı, O. S., & Al-Kuraishy, H. M. (2022) · Scientific African · doi:10.1016/j.sciaf.2022.e01407 · Cited by 36 · see citing works

Annexin A protein family in atherosclerosis

Li, Y., Wang, Y., Huang, L., Zhao, Y.-Y., Chen, L.-H., & Zhang, C. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.05.009 · Cited by 35 · see citing works

Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?

Barkas, F., Milionis, H. J., Anastasiou, G., & Liberopoulos, E. N. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110452 · Cited by 35 · see citing works

Targeting inflammation and redox aberrations by perindopril attenuates methotrexate-induced intestinal injury in rats: Role of TLR4/NF-κB and c-Fos/c-Jun pro-inflammatory pathways and PPAR-γ/SIRT1 cytoprotective signals

Sayed, A. M. M., Abdel‐Fattah, M. M., Arab, H. H., Mohamed, W. R., & Hassanein, E. H. M. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109732 · Cited by 35 · see citing works

Mucus-Penetrable Biomimetic Nanoantibiotics for Pathogen-Induced Pneumonia Treatment

Wang, Y., Ding, Q., Ma, G., Zhang, Z., Wang, J., Lu, C., Xiang, C., Qian, K., Zheng, J., Shan, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c10837 · Cited by 34 · see citing works

Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes

Khan, S., Huda, B., Bhurka, F., Patnaik, R., & Banerjee, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178429 · Cited by 36 · see citing works

Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins

Zhao, L., Ma, D., Wang, L., Su, X., Feng, L., Zhu, L., Chen, Y., Hao, Y., Wang, X., & Feng, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1301051 · Cited by 35 · see citing works

Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in atherosclerosis

Margiana, R., Alsaikhan, F., Al‐Awsi, G. R. L., Patra, I., Sivaraman, R., Fadhil, A. A., Al-Baghdady, H. F. A., Qasim, M. T., Hameed, N. M., Mustafa, Y. F., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110471 · Cited by 31 · see citing works

Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis

Li, S., He, J., Zhang, X., Cai, Y.-C., Liu, J., Nie, X., & Shi, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.966182 · Cited by 33 · see citing works

COVID-19 and the Heart and Vasculature

KADOSH, B. S., Garshick, M. S., Gaztañaga, J., Moore, K. J., Newman, J. D., Pillinger, M. H., Ramasamy, R., Reynolds, H. R., Shah, B., Hochman, J. S., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314513 · Cited by 30 · see citing works

Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk

Ahmed, S., Jacob, B., Carsons, S. E., Leon, J. D., & Reiss, A. B. (2021) · Pharmaceuticals · doi:10.3390/ph15010011 · Cited by 30 · see citing works

Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model

Xiao, S., Zhong, N., Yang, Q., Li, A., Tong, W., Zhang, Y., Yao, G., Wang, S., Liu, J., & Liu, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109163 · Cited by 30 · see citing works

In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans

Mahmoud, D. E., Faraag, A. H. I., & Abu El-Wafa, W. M. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03158-4 · Cited by 26 · see citing works

Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching

Lohia, P., Kapur, S., Benjaram, S., Cantor, Z., Mahabadi, N., Mir, T., & Badr, M. S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01336-0 · Cited by 29 · see citing works

Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale

Yu, Y., Zhang, Y., Zhu, C., Duan, T., & Rao, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02650-2 · Cited by 29 · see citing works

The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study

Umakanthan, S., Senthil, S., John, S., Madhavan, M. K., Das, J., Patil, S., Rameshwaram, R., Cintham, A., Subramaniam, V., Yogi, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.742273 · Cited by 29 · see citing works

Hepatic‐Accumulated Obeticholic Acid and Atorvastatin Self‐Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic‐Associated Fatty Liver Disease

Lu, H., Ban, Z., Xiao, K., Sun, M., Liu, Y., Chen, F., Shi, T., Chen, L., Shao, D., Zhang, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202308866 · Cited by 28 · see citing works

Regulatory impact of statins on macrophage polarization: mechanistic and therapeutic implications

Sadeghi, M., Khayati, S., Dehnavi, S., Almahmeed, W. A., Sukhorukovi, V. N., & Sahebkar, A. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae024 · Cited by 28 · see citing works

Effects of statins on myocarditis: A review of underlying molecular mechanisms

Parsamanesh, N., Karami‐Zarandi, M., Banach, M., Penson, P. E., & Sahebkar, A. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.02.008 · Cited by 28 · see citing works

Fortified gelatin-based hydrogel scaffold with simvastatin-mixed nanomicelles and platelet rich plasma as a promising bioimplant for tissue regeneration

Yahia, S., Khalil, I. A. H., & El-sherbiny, I. M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.136 · Cited by 28 · see citing works

Triterpenes as Potential Drug Candidates for Rheumatoid Arthritis Treatment

Faustino, C. M. C., Pinheiro, L. M. V., & Duarte, N. (2023) · Life · doi:10.3390/life13071514 · Cited by 28 · see citing works

Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus

Graczyk, P., Dach, A., Dyrka, K., & Pawlik, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095027 · Cited by 30 · see citing works

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

Yang, C., Wu, Y., Qian, J., & Li, J. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2412373 · Cited by 27 · see citing works

Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice

Zou, J., Yan, C., & Wan, J. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00573-z · Cited by 26 · see citing works

Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection

Li, Y.-J., Chen, C., Yang, J., & Chiu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982264 · Cited by 26 · see citing works

Trimethylamine N-oxide in cardiovascular disease: Pathophysiology and the potential role of statins

Latif, F., Mubbashir, A., Khan, M. S., Shaikh, Z., Memon, A., Alvares, J., Azhar, A., Jain, H., Ahmed, R., & Kanagala, S. G. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123304 · Cited by 26 · see citing works

Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases

Khayatan, D., Razavi, S. M., Arab, Z. N., Khanahmadi, M., Momtaz, S., Butler, A. E., Montecucco, F., Markina, Y. V., Abdolghaffari, A. H., & Sahebkar, A. (2022) · Life · doi:10.3390/life12050760 · Cited by 25 · see citing works

New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy

Al-Kuraishy, H. M., Jabir, M. S., Al-Gareeb, A. I., & Albuhadily, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102209 · Cited by 24 · see citing works

Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence

Cimmino, G., Loffredo, F. S., Rosa, G. D., & Cirillo, P. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032483 · Cited by 24 · see citing works

Purple Sweet Potato Polysaccharide Exerting an Anti-inflammatory Effect via a TLR-Mediated Pathway by Regulating Polarization and Inhibiting the Inflammasome Activation

Song, D., Niu, J., Zhang, Z., Sun, Z., Wang, D., Li, J., Yang, B., Ling, N., & Ji, C. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c07511 · Cited by 24 · see citing works

Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia

Tan, L., Kluivers, A. C. M., Cruz‐López, E. O., Broekhuizen, M., Chen, Z., Neuman, R. I., Schoenmakers, S., Ruijgrok, E. J., van de Velde, D., de Winter, B. C. M., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22457 · Cited by 24 · see citing works

Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants

Vahedian‐Azimi, A., Shojaie, S., Banach, M., Heidari‐Beni, F., Cicero, A. F. G., Khoshfetrat, M., Jamialahmadi, T., & Sahebkar, A. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1956686 · Cited by 24 · see citing works

Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation

Linnenberger, R., Hoppstädter, J., Wrublewsky, S., Ampofo, E., & Kiemer, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212480 · Cited by 23 · see citing works

The effects of statins on the function and differentiation of blood cells

Chamani, S., Kooshkaki, O., Moossavi, M., Rastegar, M., Soflaei, S. S., McCloskey, A. P., Banach, M., & Sahebkar, A. (2022) · Archives of Medical Science · doi:10.5114/aoms/158546 · Cited by 23 · see citing works

Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases

Lashgari, N., Roudsari, N. M., Zadeh, S. S. T., Momtaz, S., Abbasifard, M., Reiner, Ž., Abdolghaffari, A. H., & Sahebkar, A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01077-w · Cited by 23 · see citing works

Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives

Ovchinnikov, A. G., Potekhina, A. V., Arefieva, T. I., Filatova, A. Y., Ageev, F. T., & Belyavskiy, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094958 · Cited by 25 · see citing works

Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches

Poledniczek, M., Neumayer, C., Kopp, C. W., Schlager, O., Gremmel, T., Józkowicz, A., Gschwandtner, M. E., Koppensteiner, R., & Wadowski, P. P. (2023) · Biomedicines · doi:10.3390/biomedicines11082284 · Cited by 23 · see citing works

Lipid Metabolism: An Emerging Player in Sjögren’s Syndrome

Chang, K., Luo, P., Guo, Z., Yang, L., Pu, J., Han, F., Cai, F., Tang, J., & Wang, X. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09023-8 · Cited by 24 · see citing works

Role of Residual Inflammation as a Risk Factor Across Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Unpacking the Burden in People with Type 2 Diabetes

Ghafoury, R., Malek, M., Ismail‐Beigi, F., & Khamseh, M. E. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01743-6 · Cited by 23 · see citing works

The Effect of Statin Therapy on Serum Uric Acid Levels: A Systematic Review and Meta-analysis

Akbari, A., Razmi, M., Rafiee, M., Watts, G. F., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230207124516 · Cited by 22 · see citing works

Neutrophils for Revascularization Require Activation of CCR6 and CCL20 by TNFα

Lörchner, H., Esteve, L. C., Góes, M. E., Harzenetter, R., Brachmann, N., Gajawada, P., Günther, S., Doll, N., Pöling, J., & Braun, T. W. (2023) · Circulation Research · doi:10.1161/circresaha.123.323071 · Cited by 22 · see citing works

Sepsis-Induced Endothelial Barrier Dysfunction: Mechanisms, Pathology, and Therapeutic Advances

Wang, R., Han, Q., Fan, J., Xu, Z., Liu, W., Liu, D., Li, Y., Du, J., Sun, J., Zhang, H., et al. (2025) · Research · doi:10.34133/research.0997 · Cited by 21 · see citing works

Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathy

Shi, C., Mammadova‐Bach, E., Li, C., Liu, D., & Anders, H. (2023) · The FASEB Journal · doi:10.1096/fj.202301316r · Cited by 21 · see citing works

The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease

Yanai, H., Adachi, H., Hakoshima, M., Katsuyama, H., & Sako, A. (2024) · Biomolecules · doi:10.3390/biom14080965 · Cited by 20 · see citing works

Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer

Karthikeyan, S., Somasundaram, P., Karimi, I., Lagunas‐Rangel, F. A., Alsehli, A. M., Fredriksson, R., Jonsson, J., & Schiöth, H. B. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107912 · Cited by 20 · see citing works

The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients

Nartea, R., Mitoiu, B. I., & Ghiorghiu, I. A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040205 · Cited by 20 · see citing works

The Role of Punicalagin and Its Metabolites in Atherosclerosis and Risk Factors Associated with the Disease

Alalawi, S., Albalawi, F., & Ramji, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108476 · Cited by 17 · see citing works

Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells

Cerda, Á., Bortolin, R. H., Manríquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., Hirata, M. H., & Hirata, R. D. C. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00241-3 · Cited by 19 · see citing works

Anti-inflammatory effect of simvastatin by impeding TNF-α and interleukin-1ß pathways: antiangiogenic activity of simvastatin and simvastatin-loaded silver nanoparticles

Buabeid, M. A., Arafa, E. A., Yaseen, H. S., Umar, M. I., & Murtaza, G. (2022) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2022.2098306 · Cited by 19 · see citing works

Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art review

Parry, R., Majeed, K., Pixley, F. J., Hillis, G. S., Francis, R. J., & Schultz, C. J. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac167 · Cited by 19 · see citing works

Effect of Statins on the Blood Lipid Profile in Patients with Different Cardiovascular Diseases: A Systematic Review with Meta-analysis of Randomized Clinical Trials

Aslani, S., Razi, B., Imani, D., Mohammadi, K., Jamialahmadi, T., Reiner, Ž., & Sahebkar, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221129094921 · Cited by 19 · see citing works

NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy

Parsamanesh, N., Moossavi, M., Bahrami, A., Fereidouni, M., Barreto, G. E., & Sahebkar, A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.006 · Cited by 85 · see citing works

Effect of statins on toll-like receptors: a new insight to pleiotropic effects

Bahrami, A., Parsamanesh, N., Atkin, S. L., Banach, M., & Sahebkar, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.014 · Cited by 190 · see citing works

Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNFα in Vascular Endothelial Cells through a PXR-Dependent Mechanism

Wang, S., Xie, X., Lei, T., Zhang, K., Lai, B., Zhang, Z., Guan, Y., Mao, G., Xiao, L., & Wang, N. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.108100 · Cited by 93 · see citing works

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin

Satoh, M., Tabuchi, T., Itoh, T., & Nakamura, M. (2013) · Clinical Science · doi:10.1042/cs20130043 · Cited by 126 · see citing works

NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics

Lu, N., Cheng, W., Liu, D., Liu, G., Cui, C., Feng, C., & Wang, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.823387 · Cited by 53 · see citing works